RDC-274307

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameRDC-274307
Drug Alias NameHDAC inhibitor (Alkermes)RDC-274307
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHistone deacetylase inhibitors
TargetsHistone deacetylase
Therapy Area/IndicationsFrontotemporal Dementia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAlkermes Plc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAlkermes Plc
Active IndicationsN/A
Inactive IndicationsFrontotemporal Dementia

Other Information

ATC CodeN/A
Related LinksN/A